Reply to K. Jackson et al and W. Leppert

dc.contributor.authorHardy, J.
dc.contributor.authorQuinn, S.
dc.contributor.authorFazekas, B.
dc.contributor.authorEckermann, S.
dc.contributor.authorAgar, M.R.
dc.contributor.authorSpruyt, O.
dc.contributor.authorRowett, D.
dc.contributor.authorCurrow, D.
dc.date.issued2013
dc.descriptionLink to a related website: https://espace.library.uq.edu.au/view/UQ:299293/UQ299293_OA.pdf, Open Access via Unpaywall
dc.identifier.citationJournal of Clinical Oncology, 2013; 31(10):1375-1376
dc.identifier.doi10.1200/JCO.2012.47.9469
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.urihttps://hdl.handle.net/11541.2/124223
dc.language.isoen
dc.publisherAmerican Society of Clinical Oncology
dc.rightsCopyright 2013 American Society of Clinical Oncology
dc.source.urihttps://doi.org/10.1200/JCO.2012.47.9469
dc.subjectcancer pain
dc.subjectketamine
dc.subjectmorphine
dc.titleReply to K. Jackson et al and W. Leppert
dc.typeJournal article
pubs.publication-statusPublished
ror.mmsid9916111207301831

Files

Collections